ストックスクリーナーアプリを入手
22.12
1.61%
0.35
プレマーケット:
22.40
0.28
+1.27%
前日終値:
$21.77
開ける：
$21.81
24時間の取引高:
314.85K
Relative Volume:
1.41
時価総額：
$1.52B
収益：
-
当期純損益:
$-48.26M
株価収益率:
-28.00
EPS:
-0.7899
ネットキャッシュフロー:
$-45.04M
1週間 パフォーマンス:
+3.41%
1か月 パフォーマンス:
+16.73%
6か月 パフォーマンス:
+57.83%
1年 パフォーマンス:
+96.27%
1日の値動き範囲:
$21.81
$23.84
1週間の範囲:
$21.07
$23.84
52週間の値動き範囲:
$10.66
$24.66
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
22.12 | 1.49B | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Needham | Buy |
| 2025-06-04 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-13 | 開始されました | Guggenheim | Buy |
| 2025-03-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-02-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-16 | 開始されました | ROTH Capital | Buy |
すべてを表示
Gh Research Plc (GHRS) 最新ニュース
(GHRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Assessing GH Research (GHRS) Valuation After Positive Phase 2b Data For GH001 In Treatment Resistant Depression - Sahm
GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026 - TipRanks
GH Research (NASDAQ: GHRS) highlights Phase 2b GH001 gains in treatment-resistant depression - Stock Titan
GHRS Technical Analysis | Trend, Signals & Chart Patterns | GH RESEARCH PLC (NASDAQ:GHRS) - ChartMill
[EFFECT] GH Research PLC SEC Filing - Stock Titan
GH Research: Rapid Onset And Short Action Change The Treatment Paradigm (NASDAQ:GHRS) - Seeking Alpha
GHRS Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
H.C. Wainwright lowers GH Research stock price target on dilution By Investing.com - Investing.com South Africa
H.C. Wainwright lowers GH Research stock price target on dilution - Investing.com
Lynx1 and Weston Nichols report 17.4% stake in GH Research (NASDAQ: GHRS) - Stock Titan
Phase 2b JAMA Data and New Financing Tools Could Be A Game Changer For GH Research (GHRS) - simplywall.st
Assessing GH Research (GHRS) Valuation After Key Phase 2b Results And Phase 3 Trial Plans - Yahoo Finance
GHRS SEC FilingsGh Research Plc 10-K, 10-Q, 8-K Forms - Stock Titan
GHRS Maintained by Cantor Fitzgerald -- Price Target Raised to $35 - GuruFocus
Lynx1 discloses 15.2% stake in GHRS (GHRS) via Schedule 13G/A - Stock Titan
GHRS Maintained by CitizensPrice Target Lowered to $39.00 - GuruFocus
Cantor Fitzgerald raises GH Research stock price target on adoption outlook - Investing.com UK
These Analysts Revise Their Forecasts On GH Research After Q1 Results - Benzinga
Canaccord reiterates GH Research stock rating on phase 3 progress By Investing.com - Investing.com Nigeria
Cantor Fitzgerald raises GH Research stock price target on adoption outlook By Investing.com - Investing.com South Africa
Canaccord reiterates GH Research stock rating on phase 3 progress - Investing.com
Citizens cuts GH Research stock price target on equity financing - Investing.com
Citizens cuts GH Research stock price target on equity financing By Investing.com - Investing.com Australia
GH Research PLC announces $200 million at-the-market equity offering - Investing.com Nigeria
GH Research Launches $200 Million At-the-Market Share Offering With Stifel - TipRanks
GH Research PLC announces $200 million at-the-market equity offering By Investing.com - Investing.com South Africa
[6-K] GH Research PLC Current Report (Foreign Issuer) | GHRS SEC FilingForm 6-K - Stock Titan
GH Research Releases Q1 2026 Financial Results - AlphaStreet
GH Research PLCMay offer up to $400 million in securitiesSEC filing - marketscreener.com
Gh Research plcenters at-the-market equity offering sales agreement with StifelSEC filing - marketscreener.com
GH Research (NASDAQ: GHRS) files F-3 to register $400M in securities - Stock Titan
GH Research (NASDAQ: GHRS) launches $200M at‑the‑market share program - Stock Titan
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise - TipRanks
Earnings Flash (GHRS) GH Research Posts Q1 Loss $0.31 a Share, vs. FactSet Est of $0.29 Loss - marketscreener.com
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
GH Research (Nasdaq: GHRS) widens Q1 loss but keeps $267M cash buffer - Stock Titan
GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
Experimental depression drug GH001 prepares for Phase 3 after JAMA study - Stock Titan
GH Research PLC schedules annual general meeting for June 25 in Dublin By Investing.com - Investing.com India
GH Research PLC schedules annual general meeting for June 25 in Dublin - Investing.com UK
Gh Research Plc (GHRS) 財務データ
収益
当期純利益
現金流量
EPS
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):